Author + information
- Oliver Bruder, MD* (, )
- Anja Wagner, MD,
- Massimo Lombardi, MD and
- Heiko Mahrholdt, MD
- ↵*Elisabeth Hospital, Klara-Kopp-Weg 1, 45138 Essen, Germany
We deeply appreciate Drs. Thomas and Tavares' interest in our paper (1) and welcome their important points for further clarification.
We easily admit that some of us are enthusiasts (innovators), some are even visionaries (early adopters), but the majority are very pragmatic people who want cardiac magnetic resonance (CMR) to descend from its “Magic Mountain.” We also admit that none of the authors can be addressed as conservative (can science be conservative anyway?).
The basic aim of this registry is to let the clinical cardiologist be aware that CMR is not only ready to answer relevant questions regarding specific research and clinical aspects of cardiology but that the use of this technology has the potential to substantially change and improve everyday clinical practice. This purpose can be obtained only by analyzing a large database where data from a diffuse network of clinical centers can be collected. Thus, the present article is unavoidably preliminary, and the term “pilot-study” in the report's title was used to underscore this point.
Unfortunately, the data necessary for clarifications requested by the authors were not collected during the pilot phase of the registry. However, we agree that this information would be interesting to collect in future specific protocols.
Nevertheless, with regard to more than 60 requests for participation in the multinational phase of the EuroCMR Registry from centers all over Europe currently being processed by the Institut für Herzinfarktforschung, we have some hope that CMR has already crossed the chasm in Europe.
- American College of Cardiology Foundation